News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Forbion Announces Closing Of Initial Public Offering Of Portfolio Company uniQure



2/13/2014 8:45:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NAARDEN, The Netherlands--(BUSINESS WIRE)--Forbion Capital Partners, the leading Dutch VC firm investing in world-class healthcare technologies, is proud to announce that its portfolio company uniQure N.V. (uniQure or the company) has closed its initial public offering of ordinary shares at an initial public offering price of $17.00 per ordinary share. uniQure's ordinary shares are listed on the NASDAQ Global Select Market and began trading under the symbol "QURE" on February 5, 2014. Jefferies LLC and Leerink Partners LLC acted as joint book-running managers and Piper Jaffray & Co. acted as lead manager for the offering.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
uniQure
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES